EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease

Joshua T Skrehot iD, Dmitry Kurouski

Protein Science · 2026-06 · 35 (6)

DOI: 10.1002/pro.70635 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Protein Science, online erschienen am 26.05.2026. Verfasst von Joshua T Skrehot und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Protein Aggregation, Pathological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is characterized by the intracellular aggregation of the microtubule‐associated protein Tau. While the presence of large, insoluble neurofibrillary tangles has long been the primary focus of this research, a paradigm shift in the field now highlights smaller, soluble oligomers as the more neurotoxic Tau species leading to neuronal death and cognitive decline. This leaves the important and ill‐understood question of what molecular events lead to the conversion of healthy, functional Tau into these toxic oligomers. This review addresses the knowledge gap by investigating existing literature on the upstream mechanisms responsible for the onset of neurodegeneration and connecting it to disease pathogenesis. By synthesizing evidence from molecular biophysics, cellular biology, and neuropathology, this review summarizes the most recent understanding of factors contributing to pathological Tau aggregation, including post‐translational modifications, lipids, and metal ions, among others. This review also discusses how neurotoxic Tau aggregates contribute to the onset of AD. By connecting these factors with findings from mammalian brain studies, this review establishes a comprehensive timeline of pathology that demystifies the transition from physiological Tau to toxic oligomers and links specific molecular triggers to the onset of neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseProtein Aggregation, PathologicalHumansAnimalsProtein Processing, Post-TranslationalNeurofibrillary TanglesProtein Aggregates

Stichwörter der Autor:innen

Alzheimer's diseaseTaufibrilsoligomerspost translational modifications

Substanzen

tau ProteinsProtein Aggregates

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas, USA.
  • Department of Chemistry, Texas A&M University, College Station, Texas, USA.

ORCID-Profile: Joshua T Skrehot

Zitieren

APA

Skrehot, J. T., & Kurouski, D. (2026). Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. Protein Science, 35(6). https://doi.org/10.1002/pro.70635

Vancouver

Skrehot JT, Kurouski D. Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease. Protein Science. 2026;35(6). doi:10.1002/pro.70635

BibTeX
@article{Skrehot2026,
  author = {Skrehot, Joshua T and Kurouski, Dmitry},
  title = {Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {6},
  doi = {10.1002/pro.70635}
}
Kostenlos starten →